Assuntos
Granuloma de Corpo Estranho/complicações , Granuloma de Corpo Estranho/diagnóstico , Neoplasias Pélvicas/etiologia , Tampões de Gaze Cirúrgicos/efeitos adversos , Feminino , Granuloma de Corpo Estranho/etiologia , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios XRESUMO
We report computed tomographic and pathologic findings of an adult case of idiopathic localized dilatation of the ileum presenting as hematochezia and bowel perforation. If a cyst-like structure that has narrow communications with proximal and distal bowel loops and a layered enhancement pattern similar to those of adjacent bowels on the computed tomogram of a patient with gastrointestinal bleeding, idiopathic localized dilatation of the ileum should be suspected.
Assuntos
Hemorragia Gastrointestinal/diagnóstico por imagem , Doenças do Íleo/diagnóstico por imagem , Íleo/diagnóstico por imagem , Idoso , Diagnóstico Diferencial , Dilatação Patológica/diagnóstico por imagem , Hemorragia Gastrointestinal/etiologia , Humanos , Doenças do Íleo/complicações , Doenças do Íleo/patologia , Íleo/patologia , Masculino , Tomografia Computadorizada por Raios XRESUMO
Stable transformation of plants by Agrobacterium T-DNAs requires that the transgene insert into the host chromosome. Although most of the Agrobacterium Ti plasmid genes required for this process have been studied in depth, few plant-encoded factors have been identified, although such factors, presumably DNA repair proteins, are widely presumed to exist. It has previously been suggested that the UVH1 gene product is required for stable T-DNA integration in Arabidopsis. Here we present evidence suggesting that uvh1 mutants are essentially wild type for T-DNA integration following inoculation via the vacuum-infiltration procedure.
Assuntos
Agrobacterium tumefaciens/genética , Arabidopsis/genética , Arabidopsis/efeitos da radiação , DNA Bacteriano/genética , Raios Ultravioleta , Arabidopsis/crescimento & desenvolvimento , DNA Bacteriano/metabolismo , DNA de Cadeia Simples/genética , DNA de Cadeia Simples/metabolismo , Resistência Microbiana a Medicamentos/genética , Glucuronidase/genética , Canamicina/farmacologia , Plantas Geneticamente Modificadas , Proteínas Recombinantes/biossínteseRESUMO
Cyclin D1 and cyclin E are the mammalian G1 cydins that are both required and rate limiting for entry into S phase. Alterations in cell cycle regulators and subsequent deregulation of the cell cycle are frequently involved in tumorigenesis and/or tumor progression. We investigated the expression of cyclin D1 and cyclin E protein in 84 gastric carcinoma by immunohistochemical staining and also the relevance of each cyclin expression to the clinical outcomes. Overexpression of cyclin D1 and cyclin E was noted in 21 of 84 (25.0%) and 34 of 84 (40.5%) gastric cancer tissues, respectively. There was a significant correlation between overexpression of cyclin E and lymph node metastasis (p=0.003), recurrence (p=0.043), disease free survival (p=0.0378) and overall survival (p=0.0319), but no correlation was noted between overexpression of cyclin D1 and other clinicopathologic variables. These findings suggest that overexpression of cyclin E and cyclin D1 is a frequent finding in gastric cancer and immunohistochemical analysis for cell cycle regulators, especially cyclin E might be a useful prognostic indicator in gastric cancer.
Assuntos
Ciclina D1/biossíntese , Ciclina E/biossíntese , Neoplasias Gástricas/metabolismo , Adulto , Feminino , Humanos , Masculino , Neoplasias Gástricas/patologiaRESUMO
This study was designed to test the activity and feasibility of 5'-deoxy-5-fluorouridine (5'-DFUR) and cisplatin combination therapy in the treatment of advanced gastric cancer. Nineteen patients with inoperable and/or metastatic gastric cancer, which was histologically proven, were orally administered 5'-DFUR 1,200 mg/m2 on days 1 to 4 and days 15-18 combined with 70 mg/m2 of cisplatin being repeated every 4 weeks. Five partial responses (PRs) were achieved. Seven patients had stable disease and 6 progressed on therapy. The overall response rate was 27.7% (95% confidence interval: 9.69% to 53.5%). The median survival duration of all 18 patients was 25 weeks (9-64). The majority of patients had WHO grade I/II toxicity, but there was no treatment-related death. These data support that the combinations of oral 5'-DFUR and cisplatin are well tolerable and have a moderate activity with low toxicity in the treatment of advanced gastric cancer.